Indianapolis is home to Eli Lilly and a growing pharmaceutical corridor. Discover which companies sponsor H-1B visas for pharma professionals.
Indianapolis has been a pharmaceutical powerhouse for over a century, anchored by Eli Lilly — one of the world's largest drugmakers and one of Indiana's top H-1B sponsors. The city's pharma ecosystem extends well beyond Lilly, with Roche Diagnostics, Corteva Agriscience, Catalent, and Elevance Health (formerly Anthem) all maintaining significant operations in the region. For international pharmaceutical scientists, chemists, and biostatisticians, Indianapolis offers strong H-1B sponsorship opportunities with a Midwest cost of living.
Eli Lilly is one of the top pharma H-1B sponsors in the United States, and its Indianapolis headquarters is a major filing hub.
Indianapolis also hosts Roche Diagnostics, Corteva Agriscience, and Elevance Health — all active H-1B sponsors. Pharma filings in Indianapolis have surged alongside Lilly's expansion driven by GLP-1 drug demand. Search Wisa for verified data.
| Company | H-1B Filings | Top Roles | Approval Rate |
|---|---|---|---|
| Eli Lilly and Company | 4,850 | Research Scientist, Biostatistician | 97% |
| Roche Diagnostics | 1,920 | Software Engineer, Systems Analyst | 95% |
| Corteva Agriscience | 1,340 | Research Scientist, Data Analyst | 94% |
| Elevance Health | 2,680 | Data Engineer, Actuarial Analyst | 93% |
| Catalent Pharma Solutions | 580 | Process Engineer, Quality Scientist | 92% |
| Covance / Labcorp Drug Development | 760 | Clinical Research Scientist, Bioanalytical Chemist | 93% |
Indianapolis's pharmaceutical sector is experiencing a historic boom. Eli Lilly's market capitalization surpassed $800 billion in 2025, driven by demand for GLP-1 drugs like Mounjaro and Zepbound. This growth has translated directly into hiring — Lilly announced $20 billion in new manufacturing and R&D facilities across Indiana, creating thousands of positions that require specialized international talent in chemistry, biostatistics, clinical research, and process engineering.
The ripple effect extends throughout the Indianapolis pharma ecosystem. Contract development organizations like Catalent and Covance (Labcorp Drug Development) have expanded their Indianapolis operations to support Lilly and other clients. Roche Diagnostics' North American headquarters in Indianapolis sponsors H-1B workers for diagnostic technology and software roles. Corteva Agriscience, spun off from DowDuPont, sponsors research scientists focused on agricultural biotechnology.
Indianapolis offers a significant cost-of-living advantage over pharma hubs like Boston, New Jersey, and San Francisco. A Research Scientist earning $120,000 in Indianapolis has roughly the same purchasing power as someone earning $180,000 in the Boston area. H-1B prevailing wages reflect local costs, and the higher real wages at Indianapolis pharma companies give candidates strong odds under the wage-weighted lottery system.
Search verified H-1B filing data for Indianapolis pharmaceutical companies on Wisa.
Search Indianapolis Pharma Sponsors →Search thousands of verified H-1B sponsors by company, industry, and location.
Search H-1B Sponsors on Wisa →Yes, Eli Lilly is one of the most prolific H-1B sponsors in the pharmaceutical industry, with over 4,800 total filings. The company's global headquarters in Indianapolis is a primary filing location for Research Scientists, Biostatisticians, Clinical Scientists, and Process Engineers. Lilly's $20 billion expansion in Indiana manufacturing and R&D has significantly increased hiring of international talent. The company has a well-established immigration team and high approval rates (~97%). Positions at Lilly typically command Level 2–3 prevailing wages, which benefit from priority selection under the wage-weighted lottery.
Indianapolis has a broad pharma ecosystem beyond Eli Lilly. Key sponsors include: Roche Diagnostics (North American HQ in Indianapolis, ~1,900 filings for diagnostic tech and software roles), Corteva Agriscience (~1,300 filings for agricultural biotech research), Elevance Health/Anthem (~2,680 filings for healthcare analytics and data engineering), Catalent Pharma Solutions (contract development and manufacturing), and Covance/Labcorp Drug Development (clinical research and bioanalytical chemistry). Smaller biotech firms and CROs in the region also sponsor, though in lower volumes.
Indianapolis offers a substantial cost-of-living advantage compared to other major pharma hubs. The cost of living is roughly 35% lower than Boston, 40% lower than San Francisco, and 30% lower than the New Jersey pharma corridor. A Research Scientist earning $120,000 in Indianapolis has comparable purchasing power to someone earning $175,000–$180,000 in the Boston area. Housing costs are particularly favorable — median home prices in Indianapolis are under $280,000 compared to over $700,000 in Boston. This means H-1B workers can save more, invest more, and build financial stability faster while maintaining strong career trajectory at top pharma companies.
Yes, transitioning from F-1 OPT or STEM OPT to H-1B is a common pathway at Indianapolis pharma companies. Purdue University, Indiana University, and Butler University are nearby, and many graduates secure positions at Eli Lilly, Roche, or Corteva during their OPT period before transitioning to H-1B. STEM OPT gives you up to 36 months of work authorization, providing ample time for your employer to file an H-1B petition. The cap-gap provision allows you to continue working if your H-1B is filed for the October 1 start date. Indianapolis pharma companies generally have experienced immigration counsel who manage this transition smoothly.